(Total Views: 310)
Posted On: 04/26/2024 3:03:20 PM
Post# of 8398
Most investors who follow BIEL are familiar with Dr. Ilfeld from UCSD
He did a Study using RecoveryRx for Phantom Limb Pain relief.
He is currently working on a 120 patient Study using RecoveryRx for Surgery Pain relief. One of the specific issues they are measuring is Opioid use.
"Hypothesis 2: Nonthermal, pulsed shortwave therapy decreases opioid use in the 7 days following moderate-to-severely painful surgical procedures."
This Study had an estimated completion data of April 2024 so results should be available soon. This data could be useful regarding the 'No Pain Act' beginning in 2025.
https://clinicaltrials.ucbraid.org/trial/NCT05399355
He did a Study using RecoveryRx for Phantom Limb Pain relief.
He is currently working on a 120 patient Study using RecoveryRx for Surgery Pain relief. One of the specific issues they are measuring is Opioid use.
"Hypothesis 2: Nonthermal, pulsed shortwave therapy decreases opioid use in the 7 days following moderate-to-severely painful surgical procedures."
This Study had an estimated completion data of April 2024 so results should be available soon. This data could be useful regarding the 'No Pain Act' beginning in 2025.
https://clinicaltrials.ucbraid.org/trial/NCT05399355
(3)
(0)
